Nandita Joshi Jones
Launchpad Central (United States)(US)
Publications by Year
Research Areas
Blood Pressure and Hypertension Studies, Attention Deficit Hyperactivity Disorder, Receptor Mechanisms and Signaling, Neural and Behavioral Psychology Studies, Computational Drug Discovery Methods
Most-Cited Works
- → RNA Interference With Zilebesiran for Mild to Moderate Hypertension(2024)107 cited
- → A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children(2020)81 cited
- → Lorundrostat in Participants With Uncontrolled Hypertension and Treatment-Resistant Hypertension(2025)44 cited
- → A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder(2021)41 cited